المؤلفون: Isrid Sturm, Joachim Oertel, Stephan Oertel, Jörg Westermann

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/e7/4e/J_Med_Case_Reports_2008_Aug_14_2_275.tar.gz

وصف الملف: application/zip

العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.275.7990Test

المؤلفون: Isrid Sturm, Beate Rau, Peter M Schlag, Peter Wust, Bert Hildebr, Hanno Riess, Steffen Hauptmann, Bernd Dörken, Peter T Daniel

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: http://www.biomedcentral.com/content/pdf/1471-2407-6-124.pdfTest.

وصف الملف: application/pdf

العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.215.7923Test; http://www.biomedcentral.com/content/pdf/1471-2407-6-124.pdfTest

الإتاحة: http://www.biomedcentral.com/content/pdf/1471-2407-6-124.pdfTest

المؤلفون: James J. Lee, Colin D. Weekes, Heinz-Josef Lenz, A. Craig Lockhart, Isrid Sturm, Funan Huang, Adriaan Cleton

المصدر: International Journal of Cancer

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Colorectal cancer, Pyridines, Cetuximab, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Pharmacokinetics, Refractory, Internal medicine, Regorafenib, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Drug Interactions, Adverse effect, Cancer Therapy and Prevention, Aged, business.industry, Phenylurea Compounds, metastatic colorectal cancer, Middle Aged, medicine.disease, Treatment Outcome, Oncology, chemistry, phase 1, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Female, regorafenib, business, Hypophosphatemia, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b177dfe12a6d89487461b34905ae2e7Test
https://pubmed.ncbi.nlm.nih.gov/30958892Test

المؤلفون: Kurt Possinger, Anne Regierer, Jan Eucker, Annette Dieing, Bernd Flath, Gunnar Folprecht, Michael Geißler, Erhard Hiller, Andreas Hochhaus, Christian Jehn, Ulrich Keilholz, Konrad Klinghammer, Wolfgang Knauf, Hans-Jochem Kolb, Diana Lüftner, Matthias Möhlig, Helmut Oettle, null Oettle, null Mayer, Ulrich-Frank Pape, Gabriele Pecher, Uwe Platzbecker, Andreas Rank, Peter Reichardt, Oliver Rick, Ebel Fachkliniken, Hanno Riess, Markus Ruhnke, Markus Schaich, Andreas Schalhorn, Alexander Schmittel, Christian Scholz, Hubert Schrezenmeier, Carsten-Oliver Schulz, Bertram Wiedenmann, Isrid Sturm, Dieter Engelhardt, Ralph Naumann, Peter Schmid

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f715910fcdd723e4809cb9ca17355a8bTest
https://doi.org/10.1016/b978-3-437-21214-7.01002-6Test

المؤلفون: Benjamin Storek, Peter C. Thuss-Patience, Isrid Sturm, Annette Traore, Johanna Baak

المصدر: Supportive Care in Cancer. 22:2241-2249

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Dance, Pain medicine, Cancer therapy, law.invention, Quality of life, Randomized controlled trial, law, Neoplasms, Surveys and Questionnaires, medicine, Humans, Cancer-related fatigue, Fatigue, Aged, Pain Measurement, business.industry, Dance Therapy, Cancer, Middle Aged, medicine.disease, Oncology, Anticancer treatment, Quality of Life, Physical therapy, Female, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::400624039063f52de981497999760098Test
https://doi.org/10.1007/s00520-014-2181-8Test

المؤلفون: Isrid Sturm, Katharina Oehrlein, Sigrid Kuhn, Wolfram Pönisch, Katja Weisel, Christian Langer, Corinna Hahn-Ast

المصدر: Clinical Lymphoma Myeloma and Leukemia. 12:191-196

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Renal function, Antineoplastic Agents, urologic and male genital diseases, Dexamethasone, Impaired renal function, Recurrence, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Renal Insufficiency, Intensive care medicine, Lenalidomide, Multiple myeloma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Bortezomib, Treatment options, Hematology, Middle Aged, medicine.disease, Thalidomide, Regimen, Treatment Outcome, Female, Multiple Myeloma, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db18c4e128f542b13ddbbcf3aaffa86Test
https://doi.org/10.1016/j.clml.2012.01.001Test

المؤلفون: Heinz Haverkamp, Martin Vogelhuber, Andreas Lohri, Michael Fuchs, Lucia Nogova, Martin Sökler, Josée M. Zijlstra, Max S. Topp, Peter Borchmann, Hans-Henning Flechtner, Volker Diehl, Matthias Villalobos, Thorsten Zenz, Isrid Sturm, Andreas Rank, Andreas Engert, Andreas Josting

المساهمون: Hematology, CCA - Innovative therapy

المصدر: Engert, A, Josting, A, Haverkamp, H, Villalobos, M, Lohri, A, Sokler, M, Zijlstra-Baalbergen, J M, Sturm, I, Topp, M S, Rank, A, Zenz, T, Vogelhuber, M, Nogova, L, Borchmann, P, Fuchs, M, Flechtner, H H & Diehl, V 2010, ' Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial ', Journal of Clinical Oncology, vol. 28, no. 13, pp. 2239-2245 . https://doi.org/10.1200/JCO.2009.25.1835Test
Journal of Clinical Oncology, 28(13), 2239-2245. American Society of Clinical Oncology

مصطلحات موضوعية: Oncology, BEACOPP, Male, Cancer Research, Time Factors, medicine.medical_treatment, Kaplan-Meier Estimate, Procarbazine, law.invention, Randomized controlled trial, law, Prednisone, Risk Factors, Germany, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, Fatigue, Etoposide, Anemia, Middle Aged, Hodgkin Disease, Recombinant Proteins, Treatment Outcome, Vincristine, Female, Erythrocyte Transfusion, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Risk Assessment, Bleomycin, Young Adult, Double-Blind Method, Internal medicine, medicine, Humans, Cyclophosphamide, Erythropoietin, Neoplasm Staging, Proportional Hazards Models, Chemotherapy, business.industry, Epoetin alfa, Hodgkin's lymphoma, medicine.disease, Surgery, Epoetin Alfa, Doxorubicin, Hematinics, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::528e2fb963f78667c848c8e41ba6e607Test
https://doi.org/10.1200/jco.2009.25.1835Test

المؤلفون: Carlos Gomez-Roca, Yong-Mei Yin, Manfred P. Wirth, Hein van Poppel, Mathias Freund, Matthias W. Beckmann, Kourong Miao, Inken Hilgendorf, Eva Respondek-Dryba, Stefan Pahl, Susanne Decker, Christian Junghanss, Isrid Sturm, Susanne Osanto, Kirsten Jost, Lijuan Chen, Jean-Charles Soria, Xifeng Qian, Rolf Kreienberg, Benjamin Besse, Christoph Kahl, Su-Yu Miao, Ina Kopp, Hongfeng Guo, Virginie Prulière-Escabasse, Carsten Hirt, Malte Leithäuser, Yong-Qian Shu, Guo-Liang Wang, Christophe Massard, Christoph Röllig, Diethelm Wallwiener, L. Weißbach, Run Zhang, Achim Wöckel, Susanne Weinbrenner, Xiao-Dong Li, Monika Nothacker, Annegret Kunitz, Jianyong Li, Juliane Strack, Günter Ollenschläger, Eva Wardelmann, Hanxin Wu, Paulo N. Lopes, Walter Jonat, Falk Thiel, Estelle Escudier, Rong Wang, Sebastian Rohde, Claudia Reichelt, André, Hairong Qiu, Michael Gnant, Manfred Gaspar, Michael P. Lux, Petr Podrabsky, Li Yang, Coste, Jianfu Zhang

المصدر: Onkologie. 33:403-406

مصطلحات موضوعية: Cancer Research, Oncology, Hematology, General Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2d8a01bfd3c06959d49ab412e55d7c6aTest
https://doi.org/10.1159/000318203Test

المؤلفون: Colin D. Weekes, Funan Huang, Adriaan Cleton, James J. Lee, Albert C. Lockhart, H-J. Lenz, Isrid Sturm

المصدر: Annals of Oncology. 28:v127

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cetuximab, business.industry, Hematology, Pharmacology, chemistry.chemical_compound, Pharmacokinetics, chemistry, Internal medicine, Regorafenib, medicine, In patient, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::55da400807fd9344c617722403f8397fTest
https://doi.org/10.1093/annonc/mdx367.014Test

المؤلفون: Scott N. Gettinger, Zuzana Jirakova Trnkova, Isrid Sturm, Naiyer A. Rizvi, Matthew D. Hellmann, John Lettieri, Konstanze Diefenbach

المصدر: Clinical lung cancer. 16(6)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Pyridines, medicine.medical_treatment, Pemetrexed, Article, chemistry.chemical_compound, Internal medicine, Regorafenib, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Drug Interactions, Lung cancer, Adverse effect, Aged, Neoplasm Staging, Cisplatin, Chemotherapy, Neovascularization, Pathologic, business.industry, Contraindications, Phenylurea Compounds, Middle Aged, medicine.disease, Survival Analysis, Treatment Outcome, Tolerability, chemistry, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e59feff879cd8149e1fcab18245a25Test
https://pubmed.ncbi.nlm.nih.gov/26003007Test